Martha Stewart and Dr. Dhaval Bhanusali Launch Elm Biosciences Skincare
Martha Stewart, the esteemed 84-year-old personality, has ventured into the competitive skincare market with the launch of Elm Biosciences, a brand co-founded with her dermatologist, Dhaval Bhanusali. This new line, which has been in development for half a decade, is centered around a unique serum initially formulated specifically for Stewart. The collaboration aims to provide advanced skincare solutions, drawing on scientific research and personal efficacy.
The partnership between Stewart and Bhanusali evolved from a professional relationship into a collaborative effort focused on ingredient innovation. Bhanusali, known for his work with other beauty brands and for creating personalized topical treatments, developed a bespoke formula for Stewart. Recognizing the potential of this exclusive product, they decided to make it accessible to a wider audience, particularly those with mature skin. Their goal for Elm Biosciences extends beyond just selling products; they envision it as a community platform for individuals to share their experiences and insights on skin health.
The flagship product, the A30 Elemental Serum, is the culmination of their five-year development journey. Stewart expressed her fascination with chemistry and science, noting that the serum embodies the fruits of their labor. The serum is designed to combat senescent cells, often referred to as 'zombie' cells, which can negatively impact healthy skin cells. It features the brand's proprietary A30 Complex, a novel antioxidant blend that brightens the skin without causing irritation. Additionally, the serum incorporates bakuchiol, hyaluronic acid, blue tansy, squalane, and vitamin C, all known for their beneficial effects on aging, UV damage, pigmentation, and dehydration, while also soothing the skin.
Stewart personally attests to the serum's effectiveness, observing a significant improvement in her skin's quality. Her long-term makeup artist, Daisy Toye, also noted visible enhancements in Stewart's skin texture and firmness, reinforcing the product's claims. Despite its initial creation with mature skin in mind, Stewart emphasizes that the A30 Elemental Serum is suitable for a broad demographic, including her daughter, who is approaching 60. She believes the product supports graceful aging by enhancing the skin's natural ability to maintain its vitality.
Complementing the serum is the Inner Dose Daily Skin Supplement. While Dr. Bhanusali admits a general skepticism towards supplements, he highlights the rigorously studied ingredients in their offering. These include Polypodium Leucotomos, recommended for its benefits in reducing hyperpigmentation for pre-cancer and melasma patients, alongside vitamin D, Holy Basil leaf, and turmeric. This supplement is formulated to offer additional UV protection, hormonal balance, improved skin clarity, reduced inflammation, a strengthened skin barrier, and a brighter complexion over time.
Both Stewart and Bhanusali are committed to the scientific integrity and proven efficacy of their products. They stress that Elm Biosciences is grounded in genuine science, aiming for tangible results rather than mere marketing hype. Their ambition is to create products that consumers can trust implicitly, akin to recommendations from family. They believe that consistent use of the serum will yield increasingly noticeable benefits, setting a high benchmark for quality and performance in the skincare industry.